BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC)

115 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") as of Q4 2021.
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,550,279 shares of 22,866,677 outstanding shares and own 94.24% of the company stock.
Largest 10 shareholders include Ridgeback Capital Investments L.P. (2,164,801 shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (2,053,804 shares), JANUS HENDERSON GROUP PLC (1,695,409 shares), Point72 Asset Management, L.P. (1,572,823 shares), FMR LLC (1,460,882 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,263,471 shares), Deep Track Capital, LP (1,100,000 shares), First Light Asset Management, LLC (1,000,783 shares), SV Health Investors, LLC (918,154 shares), and Logos Global Management LP (870,000 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.